XEN-augmented Baerveldt Implantation for Refractory Childhood Glaucoma: A Retrospective Case Series

Abstract

Background: Tube implants can lead to long-term decompensation of the cornea after decades, in particular in complicated childhood glaucoma, because of a variety of causes including contact between the tube tip and the corneal endothelium. The augmentation of a XEN implant with a Baerveldt (250) tube implant, introduced 2016 by Mermoud et al for refractory glaucoma in adult patients, may reduce this risk in children. In our retrospective study, we report on the XEN-augmented Baerveldt (250) tube implant in children. Patients and Methods: Ten consecutive patients with refractory childhood glaucoma who underwent XEN-augmented Baerveldt implantation by a single surgeon (F.G.) between January 2016 and August 2018 were retrospectively analyzed. In this technique, a XEN tube was inserted under a standard scleral flap from outside into the anterior chamber and its outer end was connected to the Baerveldt (250) tube. The follow-up consisted of regular anterior and posterior segment examination with intraocular pressure (IOP) measurements using a hand-held slit lamp and a Perkins applanation tonometer and/or rebound tonometer (Icare). Results: Ten cases (6 female individuals, 4 male individuals, median age 6 years) were operated using a XEN-augmented Baerveldt implant [aphakic glaucoma, primary congenital glaucoma, secondary congenital glaucoma (Peters anomaly), ectropion uveae, and Stickler syndrome were 4, 3, 1, 1, and 1]. Before surgery (XEN-augmented Baerveldt implantation), median IOP was 31 mm Hg. At the last postoperative follow-up, the mean IOP was 18.5 mm Hg with a median follow-up period of 13 months (range, 3 to 21 mo). No shallow or flat anterior chamber was observed. In all cases, this technique could be performed without intraoperative complications. In 3 cases, however, a surgical revision was necessary. There was no prolonged postoperative hypotony or short-term corneal alteration. By using an S-shaped loop the original Baerveldt tube length could be preserved for potential future use. In a total of 6 out of 10 cases, the procedure was a complete success (IOP, ≤20 mm Hg without additional medication). Conclusions: XEN-augmented Baerveldt implantation was used for refractory pediatric glaucoma in which conventional surgery had already failed. A new additional modification using an S-shaped loop was introduced. Short-term IOP control seems promising, but long-term results are still pending and the long-term efficacy and safety must still be proven before this technique can be generally recommended.

Surgical outcomes of excisional goniotomy using the kahook dual blade in severe and refractory glaucoma: 12-month results

“…Despite these encouraging results, however, this was accompanied with relatively high rates of eyes classified as failure due to a persistent ocular hypertension (17.5%). Yet, these results are within that reported by other groups following other types of surgery in refractory glaucoma [23][24][25]. Interestingly, most patients who were considered a success at 6 months [26] remained stable through 1 year, as evidenced by the surgical success rates between months 6 and 12 (92.3% vs 82.5%) using the 18 mmHg or less threshold.…”

Transconjunctival XEN45 implantation for secondary open-angle glaucoma management in a pediatric patient with WAGR syndrome

“…Short term results were promising with a median follow-up period of 13 months and IOP levels <20 mm Hg without adjunctive medication therapy in 6 of the 10 cases. 16 …”

Efficacy and Safety of the Susanna Glaucoma Drainage Device After 1 Year of Follow-up

“…Several factors contribute to corneal complications such as tube positioning, motility, length, and size. The rather large tube of the Baerveldt or Ahmed implant may lead to continuous endothelial loss 38 because of a shorter tube-cornea distance. 39 A possible advantage of the current implant is the thinner tube compared with Ahmed and Baerveldt tubes, which may decrease the chances of tube-cornea contact.…”